Cement augmentation of the Proximal Femoral Nail Antirotation (PFNA): A multicentre randomized controlled trial
Injury Apr 28, 2018
Kammerlander C, et al. - In ambulatory patients aged 75 or older who sustained a closed, unstable trochanteric fracture, researchers compared the mobility following treatment by Proximal Femoral Nail Antirotation (PFNA) either with or without cement augmentation. Patients underwent the Timed Up and Go (TUG) test. Implant migration assessed on radiographs, quality of life measured by the Barthel Index, mobility measured by the Parker Mobility Score, and complications were also analyzed. Although, relative to the use of a non-augmented PFNA, no improvement was seen in patients’ walking ability with augmentation of the PFNA blade but this treatment strategy could potentially prevent reoperations by strengthening the osteosynthesis construct.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries